Shanshan Wang

机构：Fujian University of Traditional Chinese Medicine, Xiamen University, Chinese Academy of Medical Sciences & Peking Union Medical College, Sichuan University, Peking Union Medical College Hospital, Soochow University, First Affiliated Hospital of Xiamen University, West China Hospital of Sichuan University, Zhongshan Hospital of Xiamen University · ORCID：0000-0001-6214-1405

发表论文 40 篇 · 总被引 220 次 · h-index 8

代表论文

• Mechanisms underlying the cell-matrixed nerve grafts repairing peripheral nerve defects (2023 · Bioactive Materials · 被引 27)
• Conversion surgery intervention versus continued systemic therapy in patients with a response after PD-1/PD-L1 inhibitor-based combination therapy for initially unresectable biliary tract cancer: a retrospective cohort study (2024 · International Journal of Surgery · 被引 21)
• High baseline levels of PD-L1 reduce the heterogeneity of immune checkpoint signature and sensitize anti-PD1 therapy in lung and colorectal cancers (2025 · Cell Death and Disease · 被引 10)
• Local-regional therapy combined with toripalimab and lenvatinib in patients with advanced biliary tract cancer. (2023 · PubMed · 被引 10)
• UBC9 overexpression promotes proliferation and metastasis in gastric cancer via ATF2 (2025 · World Journal of Surgical Oncology · 被引 8)
• Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma: a real-world study (2024 · Cancer Immunology Immunotherapy · 被引 6)